Search results

63 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
UNC co-leads large clinical trial on new combo therapy for type 2 diabetes
New insulin degludec has comparable cardiovascular safety rates to insulin glargine U100 but with less risk of triggering low blood sugar.
Located in News / 2017 / June
Diabetes drug lowers risk of cardiovascular complications, kidney disease
For the first time, a large clinical trial showed across-the-board cardiovascular benefit of a diabetes drug – liraglutide – a much-needed outcome for people with type 2 diabetes.
Located in News / 2016 / June
Meet Dr. Elizabeth Estrada, UNC Children’s endocrinology chief
Dr. Elizabeth Estrada joined UNC Children's as chief of pediatric endocrinology in May 2015. She recently spoke with the editors of CARE about the road that led her to UNC and the passion she’s found in combatting the nation’s childhood obesity crisis.
Located in UNC Children's News / / CARE 2015 / Issue 6
UNC diabetes researcher featured on WRAL
TV segment focused diabetes prevention and screening and featured John Buse, MD, PhD, chief, Division of Endocrinology, executive associate dean for clinical research.
Located in News / 2015 / March
UNC clinical trials play crucial role in FDA approval for diabetes drug
Led by John Buse, MD, PhD, director of the UNC Diabetes Care Center, the clinical research of UNC doctors and the participation of thousands of patients culminates in a new, effective, and safe daily injectable drug to combat type-2 diabetes.
Located in News / 2016 / November
N.C. Children’s Hospital one of “America’s Best”
North Carolina Children’s Hospital has again been recognized by U.S. News & World Report as one of “America’s Best Children’s Hospitals.”
Located in UNC Children's News / / 2016 / June
UNC Diabetes Care Center begins recruitment for long-term study of diabetes drug efficacy
Beginning recruitment in June, the project is called the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study. UNC will enroll patients at locations in Durham and Greensboro, N.C.
Located in News / 2013 / June
Diabetes investigation in rats makes editor's pick in APS journal
An investigation into diabetes-related outcomes in a rat model, with senior author William Valdar, PhD, assistant professor of genetics at UNC, and first author Leah Solberg Woods, PhD, from the Medical College of Wisconsin, has made the editor's pick in this month's Physiological Genomics, a journal of the American Physiological Society.
Located in Vital Signs / 2013 / Feb. 7
Scientists awarded $2.4 million to study genetic variation in people with diabetes
The goal of the study is to identify genetic variations that may help predict the response to various treatment options for type 2 diabetes to reduce cardiovascular disease.
Located in News / 2012 / April
Treating pregnant women for mild gestational diabetes reduces serious birthing problems
Treating pregnant women for mild gestational diabetes resulted in fewer cesarean sections and other serious birthing problems associated with larger than average babies, according to a study conducted in part at the University of North Carolina at Chapel Hill.
Located in News / 2009 / September